Aldeyra Therapeutics’ (ALDX) “Buy” Rating Reaffirmed at HC Wainwright
HC Wainwright restated their buy rating on shares of Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) in a research note released on Monday morning,Benzinga reports. HC Wainwright currently has a $10.00 price objective on the biotechnology company’s stock. Separately, BTIG Research lowered their price target on shares of Aldeyra Therapeutics from $11.00 to $9.00 and set […]
HC Wainwright restated their buy rating on shares of Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) in a research note released on Monday morning,Benzinga reports. HC Wainwright currently has a $10.00 price objective on the biotechnology company’s stock. Separately, BTIG Research lowered their price target on shares of Aldeyra Therapeutics from $11.00 to $9.00 and set […]
